Follow
Sayantap Datta
Sayantap Datta
Verified email at cougarnet.uh.edu - Homepage
Title
Cited by
Cited by
Year
The Spatiotemporal Expression of Notch1 and Numb and Their Functional Interaction during Cardiac Morphogenesis
MW Lianjie Miao, Yangyang Lu, Anika Nusrat, Hala Y. Abdelnasser, Sayantap ...
Cells 10 (9), 2192, 2021
102021
Human arginase 1, a Jack of all trades?
J Anakha, PS Kawathe, S Datta, SS Jawalekar, UC Banerjee, AH Pande
3 Biotech 12 (10), 264, 2022
92022
Hypoplastic left heart syndrome: signaling & molecular perspectives, and the road ahead
S Datta, W Cao, M Skillman, M Wu
International Journal of Molecular Sciences 24 (20), 15249, 2023
72023
Role of gut microbial metabolites in cardiovascular diseases—current insights and the road ahead
S Datta, S Pasham, S Inavolu, KM Boini, S Koka
International Journal of Molecular Sciences 25 (18), 10208, 2024
52024
Lipophilic Vitamins in Health and Disease
PS Tappia
Springer Nature, 2024
32024
Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?
W Wang, Y Du, S Datta, JF Fowler, HT Sang, N Albadari, W Li, J Foster, ...
Genes & Diseases 12 (2), 101156, 2025
12025
High mobility group box 1 (HMGB1): molecular signaling and potential therapeutic strategies
S Datta, MA Rahman, S Koka, KM Boini
Cells 13 (23), 1946, 2024
12024
Human arginase I (Arg I)—a potential broad-spectrum anti-cancer agent: perspectives and the road ahead
S Datta, P Kawathe, SS Jawalekar, AH Pande
Res Rev J Oncol Hematol 9, 23-35, 2020
12020
High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury
S Datta, MA Rahman, S Koka, KM Boini
Frontiers in Pharmacology 15, 1540639, 2025
2025
Contribution of High Mobility Group Box 1 to Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
S Datta, G Puchchakayala, MA Rahman, SS Koka, KM Boini
Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024
2024
Membrane Raft Redox Signalling Pathway in Nicotine-Induced NLRP3 Inflammasome Activation and Podocyte Injury
MA Rahman, S Datta, SS Koka, KM Boini
Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024
2024
Interactions Between Gut Microbiota and Lipophilic Vitamins in Health and Disease
S Datta, KM Boini, S Koka
Lipophilic Vitamins in Health and Disease, 127-146, 2024
2024
Therapeutic potential and pharmacological mechanism of visnagin
P Yadav, SK Singh, S Datta, S Verma, A Verma, A Rakshit, A Bali, ...
Journal of Integrative Medicine, 2024
2024
Experimental therapy of triple negative breast cancer with next-generation of MDM2 inhibitors
W Wang, H Chen, Y Xie, S Datta, W Li, R Zhang
Cancer Research 84 (6_Supplement), 678-678, 2024
2024
Targeting oncogene and inflammation for cancer therapy
W Wang, S Datta, SE Velu, M Luo, R Zhang
Cancer Research 83 (7_Supplement), 2786-2786, 2023
2023
Dual Inhibitor of MDM2 and NFAT1 for Experimental Therapy of Breast Cancer: In Vitro and In Vivo Anticancer Activities and Newly Discovered Effects on Cancer Metabolic Pathways
W Wang, M Aguilar, S Datta, A Alley, M Tadesse, X Wang, X Gao, ...
Frontiers in Pharmacology 16, 1531667, 0
The system can't perform the operation now. Try again later.
Articles 1–16